Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?

Joanna E Fardell^{1

2}, Adam Walker^{3

4}, Raymond J Chan⁵, Janette L Vardy^{6

7}

Affiliations

¹ University of New South Wales Medicine and Health, UNSW Sydney, Australia.
² Western Sydney Youth Cancer Service, Westmead Hospital, Sydney, Australia.
³ Laboratory of Immuno Psychiatry, Neuroscience Research Australia, Randwick, Australia.
⁴ Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, Australia.
⁵ Caring Futures Institute, Flinders University, Adelaide, Australia.
⁶ Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
⁷ Concord Cancer Centre, Concord Repatriation General Hospital, Sydney, Australia.

PMID: 36964714
PMCID: PMC10121332
DOI: 10.1093/jncics/pkad026

Editorial

Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?

Joanna E Fardell et al. JNCI Cancer Spectr. 2023.

. 2023 Mar 1;7(2):pkad026.

doi: 10.1093/jncics/pkad026.

Authors

Joanna E Fardell^{1

2}, Adam Walker^{3

4}, Raymond J Chan⁵, Janette L Vardy^{6

7}

Affiliations

¹ University of New South Wales Medicine and Health, UNSW Sydney, Australia.
² Western Sydney Youth Cancer Service, Westmead Hospital, Sydney, Australia.
³ Laboratory of Immuno Psychiatry, Neuroscience Research Australia, Randwick, Australia.
⁴ Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, Australia.
⁵ Caring Futures Institute, Flinders University, Adelaide, Australia.
⁶ Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
⁷ Concord Cancer Centre, Concord Repatriation General Hospital, Sydney, Australia.

PMID: 36964714
PMCID: PMC10121332
DOI: 10.1093/jncics/pkad026

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no disclosures.

Comment on

Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer.
Lee Meeuw Kjoe PR, Kieffer JM, Small BJ, Boogerd W, Schilder CM, van der Wall E, Meershoek-Klein Kranenbarg E, van de Velde CJH, Schagen SB. Lee Meeuw Kjoe PR, et al. JNCI Cancer Spectr. 2023 Mar 1;7(2):pkad022. doi: 10.1093/jncics/pkad022. JNCI Cancer Spectr. 2023. PMID: 37004168 Free PMC article.

References

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341-1352. - PubMed
1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Lancet Oncol. 2022;23(3):382-392. - PMC - PubMed
1. Hershman DL, Shao T, Kushi LH, et al.Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529-537. - PMC - PubMed
1. Kadakia KC, Snyder CF, Kidwell KM, et al.Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer. Oncologist. 2016;21(5):539-546. - PMC - PubMed
1. Chlebowski RT, Kim J, Haque R.. Adherence to endocrine therapy in breast cancer adjuvant and prevention settings. Cancer Prev Res (Phila). 2014;7(4):378-387. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?

Affiliations

Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?

Authors

Affiliations

Conflict of interest statement

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical